Reporting cerebrospinal fluid data: Knowledge base and interpretation software

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 4, 2001, Pages 324-332

  Reiber, Hansotto ^c   Otto, Markus ^d   Trendelenburg, Christian ^a   Wormek, Arno ^b  

^a Inst fur Laboratoriumsmedizin D   (Germany)

^b Software Solutions in Medicine   (Germany)

^c Neurochemisches Labor   (Germany)

^d NONE

Author keywords

Cerebrospinal fluid; Interpretation software; Neurological diseases; Software

Indexed keywords

ANTIBODY; BRAIN PROTEIN; IMMUNOGLOBULIN; PROTEIN;

ANTIBODY PRODUCTION; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID FLOW; COMPUTER GRAPHICS; COMPUTER PROGRAM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DISPLAY SYSTEM; HUMAN; INFORMATION PROCESSING; NEUROIMMUNOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY AND SPECIFICITY;

BRAIN; CEREBROSPINAL FLUID; CHEMISTRY, CLINICAL; DATABASES, FACTUAL; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; SOFTWARE; STATISTICS; TIME FACTORS;

EID: 0035036277     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.051     Document Type: Article

References (45)

1. Reiber H. Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Multiple Sclerosis 1998; 4:99-107.
2. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2000; 184:101-22.
3. Reiber H, Sindic CJM, Thompson EJ. Cerebrospinal fluid -clinical neurochemistry of neurological diseases. Heidelberg: Springer-Verlag, 2001. In press.
4. Zettl UK, Lehmitz R, Mix E, editors. Klinische Liquordiagnostik. Berlin: Walter de Gruyter, 2001. In press.
5. Felgenhauer K. Laboratory diagnosis of neurological diseases, In: Thomas L, editor. Clinical laboratory diagnostics - use and assessment of clinical laboratory results. Frankfurt: TH-Books, 1998:1308-26.
6. Reiber H. Liquordiagnostik. In: Berlit P, editor. Klinische Neurologie. Heidelberg: Springer, 1999:148-77.
7. Reiber H. Flow rate of Cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994; 122:189-203.
8. Reiber H. CSF flow - its influence on CSF concentration of brain-derived and blood-derived proteins. In: Teelken A, Korf J, editors. Neurochemistry. NewYork: Plenum Press, 1997:51-72.
9. Reiber H. Dynamics of brain proteins in cerebrospinal fluid. Clin Chim Acta 2001. In press.
10. Lewczuk P, Reiber H, Ehrenreich H. Prothrombin in normal human cerebrospinal fluid originates from blood. Neurochem Research 1998; 23:1027-30.
11. Reiber H. Die diagnostische Bedeutung neuroimmunologischer Reaktionsmuster im Liquor cerebrospinalis. Lab Med 1995; 19:444-62.
12. Reiber H. External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem 1995; 41:256-63.
13. Tourtellotte WW. On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci 1970; 10:279-304.
14. Tourtellotte WW, Tumani, H. Multiple sclerosis cerebrospinal fluid. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple sclerosis. New York: Chapman and Hall, 1997:57-79.
15. Link H, Tibbling G. Principles of albumin and IgG disorders. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scan J Clin Lab Invest 1977; 37:397-401.
16. Souverijn JHM, Serrée HMP, Peet R, Grenzebach Smit W, Bruyn GW. Intrathecal immunoglobulin synthesis. Comparison of various formulae with the "gold standard" of isoelectric focusing. J Neurol Sci 1991; 102:11-6.
17. Öhman S, Ernerudh J, Forsberg P, Henriksson A, von Schenck H, Vrethem M. Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases. Ann Clin Biochem 1992; 29:405-10.
18. Peter JB, Bowman RL Intra-blood-brain-barrier synthesis of IgG: comparison of IgG synthesis formulae in a computer model and in 1,629 consecutive specimens. Neurology 1992; 42:510-15
19. Reiber H. Grundlagen der Liquoranalytik mit Fallbeispielen neurologischer Erkrankungen. CD-ROM Beckman Coulter 2000, Krefeld, Germany (versions are also in English and Spanish).
20. Felgenhauer K, Reiber H. The diagnostic significance of antibody specifity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Invest 1992; 70:28-37.
21. Tumani H, Nölker G, Reiber H. Relevance of cerebrospinal fluid variables for early diagnosis in neuroborreliosis. Neurology 1995; 45:1663-70.
22. Dorta-Contreras A J. Reibergramas: elemento esencial en el analisis inmunológico del liquido cefalorraquideo. Rev Neurol 1999; 28:996-8.
23. Korenke GC, Reiber H, Hunnemann DH, Hanefeld F. Intrathecal IgA synthesis in X-linked cerebral adrenoleukodystrophy. J Child Neurol 1997; 12:314-20.
24. Dorta AJ, Reiber H. Intrathecal synthesis of immunoglobulins in eosinophilic meningoencephalitis due to angiostrongylus cantonensis. Clin Diagn Lab Immunol 1998; 5:452-55.
25. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of lyme borreliosis in childhood. Acta Paediatr Suppl 1993; 386:1-76.
26. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of CNS complications in HIV infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997; 11:1-17.
27. Monteyne P, Sindic CJM. The diagnosis of tuberculous meningitis. Acta Neurol Belg 1995; 95:80-7.
28. Felgenhauer K, Schädlich HJ, Nekic M, Ackermann R. Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis? J Neurol Sci 1985; 71:291-9.
29. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Multiple Sclerosis 1998; 4:111-7.
30. Graef IT, Henze I, Reiber H. Polyspezifische Immunreaktion im ZNS bei Autoimmunerkrankungen mit ZNS-Beteiligung. Z Ärztl Fortbild 1994; 88:587-91.
31. Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato P, Fredman P, Frederiksen J, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A Consensus Report. J Neurol Neurosurg Psychiatry 1994; 57:897-902.
32. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991; 37:1152-60.
33. Sindic C, Monteyne P, Laterre E. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 1994; 54:75-80.
34. Cinque P, Cleator GM, Weber T, Monteyne P, van Loon A, Sindic CJM. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes encephalitis: a consensus report. J Neurol Neurosurg Psychiatry 1996; 61:339-45.
35. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, et al. Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF. Neurology 1999; 52:1555-62.
36. Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry 1998; 64:298-305.
37. Otto M, Esselmann H, Schulz-Schaeffer W, Neumann M, Schroter A, Ratzka P, et al. Decreased beta-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology 2000; 54:1099-102.
38. Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J. Elevated levels of tau protein in cerebrospinal fluid of patients with Creutzfeld-Jakob disease. Neurosci Lett 1997; 225:210-2.
39. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeld-Jakob disease. Ann Neurol 1998; 43:32-40.
40. Otto M, Wiltfang J, Schütz E, Zerr I, Otto A, Pfahlberg A, et al. Diagnosis of Creutzfeld-Jakob disease by measurement of S100 protein in serum prospective case-control study (see comments). Biol Med J 1998; 316:577-82.
41. Jacobi C, Reiber H. Clinical relevance of increased neuronspecific enolase concentration in cerebrospinal fluid. Clin Chim Acta 1988; 177:49-54.
42. Zerr I, Bodemer M, Räcker S, Grosche S, Poser S, Kretzschmar HA, et al. Cerebrospinal fluid concentration of neuronspecific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995; 345:1609-10.
43. Faber R, Trendelenburg C. Interpretation of CSF quantities with the knowledge-based system Pro.M.D. - cerebrospinal fluid diagnostics. J Lab Med 1997; 21:257-82.
44. Trendelenburg C, Colhoun O, Wormek A, Massey KL. Knowledge-based test result interpretation in laboratory medicine. Clin Chim Acta 1998; 278:229-42.
45. Shaw P, Reiber H, Brennan C. European Cerebrospinal Fluid Consensus Group - a TeamRoom (Lotus Notes)-Based Communication Network. Clin Chem Lab Med 2000; 38:747-51.